These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20806120)

  • 1. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
    Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
    Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
    J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
    Warkentin TE; Cook RJ; Marder VJ; Greinacher A
    J Thromb Haemost; 2010 Mar; 8(3):504-12. PubMed ID: 20050998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-onset heparin-induced thrombocytopenia and thrombosis.
    Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575
    [No Abstract]   [Full Text] [Related]  

  • 9. HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT.
    Warkentin TE; Sheppard JA; Manheim JC
    Thromb Haemost; 2014 Dec; 112(6):1319-22. PubMed ID: 25319237
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism.
    Zimrin AB; Warkentin TE
    Thromb Haemost; 2013 May; 109(5):971-3. PubMed ID: 23636478
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
    Mattioli AV; Bonetti L; Sternieri S; Mattioli G
    Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel use of plasmapheresis in a patient with heparin-induced thrombocytopenia requiring urgent insertion of a left ventricular assist device under cardiopulmonary bypass.
    Voeller RK; Melby SJ; Grizzell BE; Moazami N
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):e56-8. PubMed ID: 20723718
    [No Abstract]   [Full Text] [Related]  

  • 16. The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by "true" heparin-induced thrombocytopenia.
    Warkentin TE; Moore JC; Vogel S; Sheppard JA; Warkentin NI; Eikelboom JW
    Thromb Haemost; 2012 May; 107(5):998-1000. PubMed ID: 22371139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia associated with fondaparinux.
    Warkentin TE; Maurer BT; Aster RH
    N Engl J Med; 2007 Jun; 356(25):2653-5; discussion 2653-5. PubMed ID: 17582083
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 20. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.